Search Results

Displaying Results 1-1 of 1 "'CLLS'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Moligo Technologies and Cellectis Demonstrate Potential of Enzymatic Single-Stranded DNA for Non-Viral Gene Editing in Nature Communications

Nov 21, 2025, 07:30 ET Moligo Technologies and Cellectis Demonstrate Potential of Enzymatic Single-Stranded DNA for Non-Viral Gene Editing in Nature Communications

finish.    Cellectis' headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more, visit

More news about: Moligo Technologies

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.